Committee for Pharmaceutical Development (CPD)

Pills

Develop and commercialize your human therapeutic technology—such as a small molecule or biologic—with support from the Committee for Pharmaceutical Development (CPD) Program.

How we can help

Awardees

2020

2020

Li Ou, PhD and Chester Whitley, MD, PhD, Department of Pediatrics

Project title: A novel gene editing platform to treat Tay-Sachs and Sandhoff diseases

2019

2019

James M. Ervasti, PhD, and David D. Thomas, PhD, and Joseph M. Muretta, PhD, Department of Biochemistry, Molecular Biology and Biophysics, Medical School

Project title: Mini-/Micro-Dystrophin Actin Binding Domain 1 Gain-of-Affinity

Sandra Armstrong, PhD, Department of Microbiology and Immunology

Project title: Developing improved pertussis vaccines

Ronald Siegel, PhD, Department of Pharmaceutics and James Cloyd, PhD, Department of Experimental and Clinical Pharmacology

Project title: Development of a Prodrug/Enzyme Nasal Spray for Rapid Delivery of Diazepam for Treatment of Seizure Emergencies

2018

2018

Jon Hawkinson, PhD, Institute for Therapeutics Discovery & Development

Project title: Critical path studies to nominate BINTA as a preclinical development candidate to treat chronic pain devoid of opioid side effect liability

2016

2016

George Wilcox, Daniel Bruce, Philip Portoghese, and Carolyn Fairbanks

Project title: Peripherally restricted combination therapy for inflammatory or cancer-related chronic pain

2015

2015

Gwenyth Fischer, MD, Medical School, Department of Pediatrics

Project title: Epinephrine Drug-delivery Device for use in Pediatric Cardiac Arrest

Amber Lockridge, Medical School, Department of Neuroscience

Project title: The Use of D-serine as a Novel Insulin Secretagogue and Oral Antidiabetic

2014

2014

Gregory Beilman, MD, Medical School, Department of Surgery

Project title: Beta-hydroxybutyrate/melatonin (BHB/M) for the Treatment of Trauma-induced Acute Blood Loss

Lester Drewes, PhD, Medical School, Department of Biomedical Sciences, and Venkatram Mereddy, PhD, College of Pharmacy, Department of Pharmacy Practice and Pharmaceutical Sciences

Project title: Development of Novel Drugs for High Risk Triple Negative Breast Cancer Treatment

Jayanth Panyam, PhD, College of Pharmacy, Department of Pharmaceutics

Project title: Antibody Targeting Metastases in triple Negative Breast Cancer

2013

2013

Jayanth Panyam, PhD, College of Pharmacy, Department of Pharmaceutics

Project title: Surface Functionalized Nanoparticles for Improved Chemotherapeutic Efficacy

Jayanth Panyam, PhD, College of Pharmacy, Department of Pharmaceutics

Project title: Silicate Prodrug Nanoparticles of Paclitaxel

Chun Wang, PhD, College of Science and Engineering, Department of Biomedical Engineering

Project title: Semi-solid Polymer Delivery Systems for Immunotherapy against Melanoma

2012

2012

Daniel Vallera, PhD, Medical School, Department of Radiation Oncology

Project title: Developing Biological Drugs Targeting Chemo-Refractory Carcinoma

Carston R. Wagner, PhD, College of Pharmacy, Department of Medicinal Chemistry

Project title: In vivo Proof-of-Concept Studies on Chemically Self Assembled Nanostructures (CSANS) as Targeted Diagnostic Imaging and Drug Delivery agents for Brain Cancer

Contact

Sandra Wells, PhD
Assistant Director
Office of Discovery and Translation
[email protected]
612-625-3073